The evolution of traumatic brain injury in a rat focal contusion model

NMR in Biomedicine

Volumn 26, Issue 4, 2013, Pages 468-479

  Turtzo, L Christine ^a,b   Budde, Matthew D ^b   Gold, Eric M ^a,b   Lewis, Bobbi K ^b   Janes, Lindsay ^a,b   Yarnell, Angela ^c   Grunberg, Neil E ^c   Watson, William ^c   Frank, Joseph A ^b,d  

^a UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c Uniformed Services University of the Health Sciences and the Walter Reed National Military Medical Center   (United States)

^d NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING   (United States)

Author keywords

Autofluorescence; Controlled cortical impact; Hemorrhage; MRI; Traumatic brain injury

Indexed keywords

BIOLOGY; MAGNETIC RESONANCE IMAGING; RATS;

AUTOFLUORESCENCE; BIOLOGICAL VARIABILITY; CONTROLLED CORTICAL IMPACT; FEMALE WISTAR RATS; HEMORRHAGE; HISTOLOGICAL EXAMINATION; STANDARD DEVIATION; TRAUMATIC BRAIN INJURIES;

BRAIN;

HEMOSIDERIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CONTUSION; BRAIN CORTEX LESION; BRAIN HEMORRHAGE; BRAIN SIZE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; IN VIVO STUDY; MOTOR CORTEX; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; RAT; TRAUMATIC BRAIN INJURY; ANIMAL; ANIMAL BEHAVIOR; BRAIN CORTEX; BRAIN INJURY; COMPLICATION; CONTUSION; DISEASE MODEL; FLUORESCENCE MICROSCOPY; ORGAN SIZE; PATHOLOGY; WISTAR RAT;

RATTUS; RATTUS NORVEGICUS;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN INJURIES; CEREBRAL CORTEX; CEREBRAL HEMORRHAGE; CONTUSIONS; DISEASE MODELS, ANIMAL; FEMALE; MAGNETIC RESONANCE IMAGING; MICROSCOPY, FLUORESCENCE; ORGAN SIZE; RATS, WISTAR;

EID: 84875054190     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.2886     Document Type: Article

References (78)

1. Faul M, Xu L, Wald MM, Coronado VG. Traumatic brain injury in the United States: emergency department visits, hospitalizations and deaths 2002-2006. In: US Department of Health and Human Services CfDCaP, Editor. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Injury Prevention and Control; 2010. Available at: www.cdcgov/TraumaticBrainInjury.
2. Bell RS, Vo AH, Neal CJ, Tigno J, Roberts R, Mossop C, Dunne JR, Armonda RA. Military traumatic brain and spinal column injury: a 5-year study of the impact of blast and other military grade weaponry on the central nervous system. J. Trauma 2009; 66: S104-S111.
3. Risdall JE, Menon DK. Traumatic brain injury. Philos. Trans. R. Soc. London, B: Biol. Sci. 2011; 366: 241-250.
4. Roberts I, Schierhout G, Alderson P. Absence of evidence for the effectiveness of five interventions routinely used in the intensive care management of severe head injury: a systematic review. J. Neurol. Neurosurg. Psychiatry 1998; 65: 729-733.
5. Marklund N, Hillered L. Animal modelling of traumatic brain injury in preclinical drug development: where do we go from here? Br. J. Pharmacol. 2011; 164: 1207-1229.
6. Andriessen TM, Jacobs B, Vos PE. Clinical characteristics and pathophysiological mechanisms of focal and diffuse traumatic brain injury. J. Cell. Mol. Med. 2010; 14: 2381-2392.
7. Albensi BC, Knoblach SM, Chew BG, O'Reilly MP, Faden AI, Pekar JJ. Diffusion and high resolution MRI of traumatic brain injury in rats: time course and correlation with histology. Exp. Neurol. 2000; 162: 61-72.
8. Kochanek PM, Hendrich KS, Dixon CE, Schiding JK, Williams DS, Ho C. Cerebral blood flow at one year after controlled cortical impact in rats: assessment by magnetic resonance imaging. J. Neurotrauma 2002; 19: 1029-1037.
9. Thomale UW, Griebenow M, Mautes A, Beyer TF, Dohse NK, Stroop R, Sakowitz OW, Unterberg AW, Stover JF. Heterogeneous regional and temporal energetic impairment following controlled cortical impact injury in rats. Neurol. Res. 2007; 29: 594-603.
10. Obenaus A, Robbins M, Blanco G, Galloway NR, Snissarenko E, Gillard E, Lee S, Curras-Collazo M. Multi-modal magnetic resonance imaging alterations in two rat models of mild neurotrauma. J. Neurotrauma 2007; 24: 1147-1160.
11. Kharatishvili I, Sierra A, Immonen RJ, Grohn OH, Pitkanen A. Quantitative T2 mapping as a potential marker for the initial assessment of the severity of damage after traumatic brain injury in rat. Exp. Neurol. 2009; 217: 154-164.
12. Immonen RJ, Kharatishvili I, Grohn H, Pitkanen A, Grohn OH. Quantitative MRI predicts long-term structural and functional outcome after experimental traumatic brain injury. Neuroimage 2009; 45: 1-9.
13. Immonen RJ, Kharatishvili I, Niskanen JP, Grohn H, Pitkanen A, Grohn OH. Distinct MRI pattern in lesional and perilesional area after traumatic brain injury in rat - 11months follow-up. Exp. Neurol. 2009; 215: 29-40.
14. Immonen R, Heikkinen T, Tahtivaara L, Nurmi A, Stenius TK, Puolivali J, Tuinstra T, Phinney AL, Van Vliet B, Yrjanheikki J, Grohn O. Cerebral blood volume alterations in the perilesional areas in the rat brain after traumatic brain injury - comparison with behavioral outcome. J. Cereb. Blood Flow Metab. 2010; 30: 1318-1328.
15. Bouilleret V, Cardamone L, Liu YR, Fang K, Myers DE, O'Brien TJ. Progressive brain changes on serial manganese-enhanced MRI following traumatic brain injury in the rat. J. Neurotrauma 2009; 26: 1999-2013.
16. Hayward NM, Tuunanen PI, Immonen R, Ndode-Ekane XE, Pitkanen A, Grohn O. Magnetic resonance imaging of regional hemodynamic and cerebrovascular recovery after lateral fluid-percussion brain injury in rats. J. Cereb. Blood Flow Metab. 2011; 31: 166-177.
17. Li L, Jiang Q, Qu CS, Ding GL, Li QJ, Wang SY, Lee JH, Lu M, Mahmood A, Chopp M. Transplantation of marrow stromal cells restores cerebral blood flow and reduces cerebral atrophy in rats with traumatic brain injury: in vivo MRI study. J. Neurotrauma 2011; 28: 535-545.
18. Colgan NC, Cronin MM, Gobbo OL, O'Mara SM, O'Connor WT, Gilchrist MD. Quantitative MRI analysis of brain volume changes due to controlled cortical impact. J. Neurotrauma 2010; 27: 1265-1274.
19. Dixon CE, Clifton GL, Lighthall JW, Yaghmai AA, Hayes RL. A controlled cortical impact model of traumatic brain injury in the rat. J. Neurosci. Methods 1991; 39: 253-262.
20. Kochanek PM, Marion DW, Zhang W, Schiding JK, White M, Palmer AM, Clark RS, O'Malley ME, Styren SD, Ho C, DeKosky ST. Severe controlled cortical impact in rats: assessment of cerebral edema, blood flow, and contusion volume. J. Neurotrauma 1995; 12: 1015-1025.
21. Clark RS, Kochanek PM, Dixon CE, Chen M, Marion DW, Heineman S, DeKosky ST, Graham SH. Early neuropathologic effects of mild or moderate hypoxemia after controlled cortical impact injury in rats. J. Neurotrauma 1997; 14: 179-189.
22. Brody DL, Mac Donald C, Kessens CC, Yuede C, Parsadanian M, Spinner M, Kim E, Schwetye KE, Holtzman DM, Bayly PV. Electromagnetic controlled cortical impact device for precise, graded experimental traumatic brain injury. J. Neurotrauma 2007; 24: 657-673.
23. Shohami E, Novikov M, Bass R. Long-term effect of HU-211, a novel non-competitive NMDA antagonist, on motor and memory functions after closed head injury in the rat. Brain Res. 1995; 674: 55-62.
24. Hamm RJ. Neurobehavioral assessment of outcome following traumatic brain injury in rats: an evaluation of selected measures. J. Neurotrauma 2001; 18: 1207-1216.
25. Mahmood A, Lu D, Wang L, Li Y, Lu M, Chopp M. Treatment of traumatic brain injury in female rats with intravenous administration of bone marrow stromal cells. Neurosurgery 2001; 49: 1196-1203; discussion 1203-1204.
26. Mahmood A, Lu D, Lu M, Chopp M. Treatment of traumatic brain injury in adult rats with intravenous administration of human bone marrow stromal cells. Neurosurgery 2003; 53: 697-702; discussion 702-703.
27. Marti M, Mela F, Fantin M, Zucchini S, Brown JM, Witta J, Di Benedetto M, Buzas B, Reinscheid RK, Salvadori S, Guerrini R, Romualdi P, Candeletti S, Simonato M, Cox BM, Morari M. Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease. J. Neurosci. 2005; 25: 9591-9601.
28. Cole JT, Yarnell A, Kean WS, Gold E, Lewis B, Ren M, McMullen DC, Jacobowitz DM, Pollard HB, O'Neill JT, Grunberg NE, Dalgard CL, Frank JA, Watson WD. Craniotomy: true sham for traumatic brain injury, or a sham of a sham? J. Neurotrauma 2011; 28: 359-369.
29. Onyszchuk G, Al-Hafez B, He YY, Bilgen M, Berman NE, Brooks WM. A mouse model of sensorimotor controlled cortical impact: characterization using longitudinal magnetic resonance imaging, behavioral assessments and histology. J. Neurosci. Methods 2007; 160: 187-196.
30. Onyszchuk G, He YY, Berman NE, Brooks WM. Detrimental effects of aging on outcome from traumatic brain injury: a behavioral, magnetic resonance imaging, and histological study in mice. J. Neurotrauma 2008; 25: 153-171.
31. Onyszchuk G, Levine SM, Brooks WM, Berman NE. Post-acute pathological changes in the thalamus and internal capsule in aged mice following controlled cortical impact injury: a magnetic resonance imaging, iron histochemical, and glial immunohistochemical study. Neurosci. Lett. 2009; 452: 204-208.
32. Jiang Q, Qu C, Chopp M, Ding GL, Davarani SP, Helpern JA, Jensen JH, Zhang ZG, Li L, Lu M, Kaplan D, Hu J, Shen Y, Kou Z, Li Q, Wang S, Mahmood A. MRI evaluation of axonal reorganization after bone marrow stromal cell treatment of traumatic brain injury. NMR Biomed. 2011; 24: 1119-1128.
33. McClintock MK. Estrous synchrony and its mediation by airborne chemical communication (Rattus norvegicus). Horm. Behav. 1978; 10: 264-275.
34. Mandl AM. The phases of the oestrous cycle in the adult white rat. J. Exp. Biol. 1951; 28: 576-584.
35. Westwood FR. The female rat reproductive cycle: a practical histological guide to staging. Toxicol. Pathol. 2008; 36: 375-384.
36. Herson PS, Koerner IP, Hurn PD. Sex, sex steroids, and brain injury. Semin. Reprod. Med. 2009; 27: 229-239.
37. Turtzo LC, McCullough LD. Sex-specific responses to stroke. Future Neurol. 2010; 5: 47-59.
38. Roof RL, Duvdevani R, Stein DG. Gender influences outcome of brain injury: progesterone plays a protective role. Brain Res. 1993; 607: 333-336.
39. Roof RL, Duvdevani R, Braswell L, Stein DG. Progesterone facilitates cognitive recovery and reduces secondary neuronal loss caused by cortical contusion injury in male rats. Exp. Neurol. 1994; 129: 64-69.
40. Roof RL, Duvdevani R, Heyburn JW, Stein DG. Progesterone rapidly decreases brain edema: treatment delayed up to 24hours is still effective. Exp. Neurol. 1996; 138: 246-251.
41. Bramlett HM, Dietrich WD. Neuropathological protection after traumatic brain injury in intact female rats versus males or ovariectomized females. J. Neurotrauma 2001; 18: 891-900.
42. O'Connor CA, Cernak I, Johnson F, Vink R. Effects of progesterone on neurologic and morphologic outcome following diffuse traumatic brain injury in rats. Exp. Neurol. 2007; 205: 145-153.
43. Sena ES, van der Worp HB, Bath PM, Howells DW, Macleod MR. Publication bias in reports of animal stroke studies leads to major overstatement of efficacy. PLoS Biol. 2010; 8: e1000344.
44. Harting MT, Sloan LE, Jimenez F, Baumgartner J, Cox CS, Jr. Subacute neural stem cell therapy for traumatic brain injury. J. Surg. Res. 2009; 153: 188-194.
45. Meng Y, Xiong Y, Mahmood A, Zhang Y, Qu C, Chopp M. Dose-dependent neurorestorative effects of delayed treatment of traumatic brain injury with recombinant human erythropoietin in rats. J. Neurosurg. 2011; 115: 550-560.
46. Walker PA, Harting MT, Jimenez F, Shah SK, Pati S, Dash PK, Cox CS, Jr. Direct intrathecal implantation of mesenchymal stromal cells leads to enhanced neuroprotection via an NFkappaB-mediated increase in interleukin-6 production. Stem Cells Dev. 2010; 19: 867-876.
47. Walker PA, Shah SK, Jimenez F, Gerber MH, Xue H, Cutrone R, Hamilton JA, Mays RW, Deans R, Pati S, Dash PK, Cox CS, Jr. Intravenous multipotent adult progenitor cell therapy for traumatic brain injury: preserving the blood brain barrier via an interaction with splenocytes. Exp. Neurol. 2010; 225: 341-352.
48. Ioannidis JP. Why most published research findings are false. PLoS Med. 2005; 2: e124.
49. van der Worp HB, Howells DW, Sena ES, Porritt MJ, Rewell S, O'Collins V, Macleod MR. Can animal models of disease reliably inform human studies? PLoS Med. 2010; 7: e1000245.
50. Cortez SC, McIntosh TK, Noble LJ. Experimental fluid percussion brain injury: vascular disruption and neuronal and glial alterations. Brain Res. 1989; 482: 271-282.
51. McIntosh TK, Vink R, Noble L, Yamakami I, Fernyak S, Soares H, Faden AL. Traumatic brain injury in the rat: characterization of a lateral fluid-percussion model. Neuroscience 1989; 28: 233-244.
52. Sutton RL, Lescaudron L, Stein DG. Unilateral cortical contusion injury in the rat: vascular disruption and temporal development of cortical necrosis. J. Neurotrauma 1993; 10: 135-149.
53. Dietrich WD, Alonso O, Halley M. Early microvascular and neuronal consequences of traumatic brain injury: a light and electron microscopic study in rats. J. Neurotrauma 1994; 11: 289-301.
54. Iwamoto Y, Yamaki T, Murakami N, Umeda M, Tanaka C, Higuchi T, Aoki I, Naruse S, Ueda S. Investigation of morphological change of lateral and midline fluid percussion injury in rats, using magnetic resonance imaging. Neurosurgery 1997; 40: 163-167.
55. Rosell A, Foerch C, Murata Y, Lo EH. Mechanisms and markers for hemorrhagic transformation after stroke. Acta Neurochir. Suppl. 2008; 105: 173-178.
56. Kurland D, Hong C, Aarabi B, Gerzanich V, Simard JM. Hemorrhagic progression of a contusion after traumatic brain injury: a review. J. Neurotrauma 2012; 29: 19-31.
57. Simard JM, Kilbourne M, Tsymbalyuk O, Tosun C, Caridi J, Ivanova S, Keledjian K, Bochicchio G, Gerzanich V. Key role of sulfonylurea receptor 1 in progressive secondary hemorrhage after brain contusion. J. Neurotrauma 2009; 26: 2257-2267.
58. Oertel M, Kelly DF, McArthur D, Boscardin WJ, Glenn TC, Lee JH, Gravori T, Obukhov D, McBride DQ, Martin NA. Progressive hemorrhage after head trauma: predictors and consequences of the evolving injury. J. Neurosurg. 2002; 96: 109-116.
59. Sifri ZC, Homnick AT, Vaynman A, Lavery R, Liao W, Mohr A, Hauser CJ, Manniker A, Livingston D. A prospective evaluation of the value of repeat cranial computed tomography in patients with minimal head injury and an intracranial bleed. J. Trauma 2006; 61: 862-867.
60. Flint AC, Manley GT, Gean AD, Hemphill JC 3rd, Rosenthal G. Post-operative expansion of hemorrhagic contusions after unilateral decompressive hemicraniectomy in severe traumatic brain injury. J. Neurotrauma 2008; 25: 503-512.
61. Alahmadi H, Vachhrajani S, Cusimano MD. The natural history of brain contusion: an analysis of radiological and clinical progression. J. Neurosurg. 2010; 112: 1139-1145.
62. Zhu J, Zhou L, XingWu F. Tracking neural stem cells in patients with brain trauma. N. Engl. J. Med. 2006; 355: 2376-2378.
63. Foley LM, Hitchens TK, Ho C, Janesko-Feldman KL, Melick JA, Bayir H, Kochanek PM. Magnetic resonance imaging assessment of macrophage accumulation in mouse brain after experimental traumatic brain injury. J. Neurotrauma 2009; 26: 1509-1519.
64. Cheng JL, Yang YJ, Li HL, Wang J, Wang MH, Zhang Y. In vivo tracing of superparamagnetic iron oxide-labeled bone marrow mesenchymal stem cells transplanted for traumatic brain injury by susceptibility weighted imaging in a rat model. Chin. J. Traumatol. 2010; 13: 173-177.
65. Belayev L, Obenaus A, Zhao W, Saul I, Busto R, Wu C, Vigdorchik A, Lin B, Ginsberg MD. Experimental intracerebral hematoma in the rat: characterization by sequential magnetic resonance imaging, behavior, and histopathology. Effect of albumin therapy. Brain Res. 2007; 1157: 146-155.
66. Kumar N. Superficial siderosis: associations and therapeutic implications. Arch. Neurol. 2007; 64: 491-496.
67. Kakeda S, Korogi Y, Ohnari N, Nishimura J, Moriya J, Yamamoto J, Nishizawa S. Superficial siderosis associated with a chronic subdural hematoma: T2-weighted MR imaging at 3T. Acad. Radiol. 2010; 17: 871-876.
68. Nanda S, Sharma SG, Longo S. Superficial siderosis - mechanism of disease: an alternative hypothesis. Ann. Clin. Biochem. 2010; 47: 275-278.
69. Kellermier H, Wang G, Wiley C. Iron localization in superficial siderosis of the central nervous system. Neuropathology 2009; 29: 187-195.
70. Imaizumi T, Horita Y, Hashimoto Y, Niwa J. Dotlike hemosiderin spots on T2*-weighted magnetic resonance imaging as a predictor of stroke recurrence: a prospective study. J. Neurosurg. 2004; 101: 915-920.
71. Dierksen GA, Skehan ME, Khan MA, Jeng J, Nandigam RN, Becker JA, Kumar A, Neal KL, Betensky RA, Frosch MP, Rosand J, Johnson KA, Viswanathan A, Salat DH, Greenberg SM. Spatial relation between microbleeds and amyloid deposits in amyloid angiopathy. Ann. Neurol. 2010; 68: 545-548.
72. Berman SC, Galpoththawela C, Gilad AA, Bulte JW, Walczak P. Long-term MR cell tracking of neural stem cells grafted in immunocompetent versus immunodeficient mice reveals distinct differences in contrast between live and dead cells. Magn. Reson. Med. 2011; 65: 564-574.
73. Giesel FL, Stroick M, Griebe M, Troster H, von der Lieth CW, Requardt M, Rius M, Essig M, Kauczor HU, Hennerici MG, Fatar M. Gadofluorine m uptake in stem cells as a new magnetic resonance imaging tracking method: an in vitro and in vivo study. Invest. Radiol. 2006; 41: 868-873.
74. Agudelo CA, Tachibana Y, Noboru T, Iida H, Yamaoka T. Long-term in vivo magnetic resonance imaging tracking of endothelial progenitor cells transplanted in rat ischemic limbs and their angiogenic potential. Tissue Eng. Part A 2011; 17: 2079-2089.
75. Agudelo CA, Tachibana Y, Hurtado AF, Ose T, Iida H, Yamaoka T. The use of magnetic resonance cell tracking to monitor endothelial progenitor cells in a rat hindlimb ischemic model. Biomaterials 2012; 33: 2439-2448.
76. Faucher L, Guay-Begin AA, Lagueux J, Cote MF, Petitclerc E, Fortin MA. Ultra-small gadolinium oxide nanoparticles to image brain cancer cells in vivo with MRI. Contrast Media Mol. Imaging 2011; 6: 209-218.
77. Anderson SA, Lee K, Frank JA. Gadolinium fullerenol as a paramagnetic contrast agent for cell labeling. Invest. Radiol. 2006; 41: 332-338.
78. Faucher L, Tremblay M, Lagueux J, Gossuin Y, Fortin MA. Rapid synthesis of PEGylated Ultra-small gadolinium oxide nanoparticles for cell labeling and tracking with MRI. ACS Appl. Mater. Interfaces 2012; 4: 4506-4515.